Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 20, 2023
Prospective Assessment of Otologic Adverse Events due to Teprotumumab: Preliminary ResultsEmily Kay-Rivest, Irina Belinsky, Anna Kozlova, et al.The Journal of Allergy and Clinical Immunology. Global|May 6, 2024
Combined therapy with IL-1 and JAK inhibitors in a patient with the NLRP1 gene mutation and a complex inflammatory phenotypeVasily Burlakov, Anna Kozlova, Dmitry Pershin, et al.Biomedicines|January 23, 2024
The Application of Ejaculate-Based Shotgun Proteomics for Male Infertility ScreeningTimur Shkrigunov, Victor Zgoda, Peter Klimenko, et al.Ocular Oncology and Pathology|June 9, 2020
Quality of Life Concerns in Patients with Uveal Melanoma after Initial DiagnosisChristopher A Barker, Anna Kozlova, Alexander N Shoushtari, et al.International Journal of Molecular Sciences|July 12, 2025
Ovarian Cancer: Multi-Omics Data IntegrationAnna Kliuchnikova, Arina Gordeeva, Aziz Abdurakhimov, et al.Biology|December 22, 2023
Comparison of Alternative Splicing Landscapes Revealed by Long-Read Sequencing in Hepatocyte-Derived HepG2 and Huh7 Cultured Cells and Human Liver TissueAnna Kozlova, Elizaveta Sarygina, Kseniia Deinichenko, et al.Advanced Healthcare Materials|October 18, 2014
Photopatterning of multifunctional hydrogels to direct adult neural precursor cellsMikhail V Tsurkan, Richard Wetzel, Heidi R Pérez-Hernández, et al.International Journal of Molecular Sciences|November 14, 2023
Principal Component Analysis of Alternative Splicing Profiles Revealed by Long-Read ONT Sequencing in Human Liver Tissue and Hepatocyte-Derived HepG2 and Huh7 Cell LinesElizaveta Sarygina, Anna Kozlova, Kseniia Deinichenko, et al.The Journal of Allergy and Clinical Immunology|December 18, 2020
HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndromeAlexandra Laberko, Vasiliy Burlakov, Sarah Maier, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 5, 2024
Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF InhibitorZhaohui Yang, Panfeng Tao, Xu Han, et al.Pageof 3